Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: South Korea Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20073
20084
20104
20112
20134
20144
20152
20161
20173
20194
20205
20213
20222
20233
20242
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting20
Recruiting11
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Pfizer7
Merck Sharp & Dohme LLC5
Aragon Pharmaceuticals, Inc.4
FutureChem3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
Sanofi3
Amgen2
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms58
Neoplasm Metastasis4
Neoplasms4
Bulbo-Spinal Atrophy, X-Linked2
Urogenital Neoplasms2
Adenocarcinoma1
Genital Diseases1
Genital Neoplasms, Male1
Kidney Neoplasms1
Male Urogenital Diseases1

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.